163 related articles for article (PubMed ID: 18398385)
1. Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose.
Rennels MB; Black S; Woo EJ; Campbell S; Edwards KM
Pediatr Infect Dis J; 2008 May; 27(5):464-5. PubMed ID: 18398385
[TBL] [Abstract][Full Text] [Related]
2. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
[TBL] [Abstract][Full Text] [Related]
3. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
4. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.
Jackson LA; Starkovich P; Dunstan M; Yu O; Nelson J; Dunn J; Rees T; Zavitkovsky A; Maus D; Froeschle JE; Decker M
Pediatrics; 2008 Mar; 121(3):e646-52. PubMed ID: 18310184
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children.
Marshall HS; Gold MS; Gent R; Quinn PJ; Piotto L; Clarke MF; Roberton DM
Pediatrics; 2006 Oct; 118(4):1501-9. PubMed ID: 17015541
[TBL] [Abstract][Full Text] [Related]
7. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.
Rennels MB; Deloria MA; Pichichero ME; Losonsky GA; Englund JA; Meade BD; Anderson EL; Steinhoff MC; Edwards KM
Pediatrics; 2000 Jan; 105(1):e12. PubMed ID: 10617749
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
[TBL] [Abstract][Full Text] [Related]
9. Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.
Bults M; Kemmeren JM; van der Maas NA
Vaccine; 2007 Jul; 25(29):5272-7. PubMed ID: 17573165
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial.
Jackson LA; Dunstan M; Starkovich P; Dunn J; Yu O; Nelson JC; Rees T; Zavitkovsky A
Pediatrics; 2006 Mar; 117(3):620-5. PubMed ID: 16510639
[TBL] [Abstract][Full Text] [Related]
11. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
12. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group.
Liese JG; Stojanov S; Zink TH; Froeschle J; Klepadlo R; Kronwitter A; Harzer E; Jow S; Belohradsky BH
Pediatr Infect Dis J; 2001 Oct; 20(10):981-8. PubMed ID: 11642633
[TBL] [Abstract][Full Text] [Related]
15. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
16. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old.
Quinn P; Gold M; Royle J; Buttery J; Richmond P; McIntyre P; Wood N; Lee SS; Marshall H
Vaccine; 2011 Jun; 29(25):4230-7. PubMed ID: 21497629
[TBL] [Abstract][Full Text] [Related]
18. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines.
Rennels MB
Semin Pediatr Infect Dis; 2003 Jul; 14(3):196-8. PubMed ID: 12913831
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review.
Jacquet JM; Bégué P; Grimprel E; Reinert P; Sandbu S; Silfverdal SA; Faldella G; Nolan T; Lambert S; Richmond P; Marshall H; Roberton D; Schuerman L
Vaccine; 2006 Mar; 24(13):2440-8. PubMed ID: 16406224
[TBL] [Abstract][Full Text] [Related]
20. Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years.
Weston WM; Klein NP
Expert Rev Vaccines; 2008 Nov; 7(9):1309-20. PubMed ID: 18980534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
